Back

Non-invasive assessment of left ventricular hemodynamic forces in hypertrophic cardiomyopathy

30 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Giorgia Panichella

Careggi University Hospital (AOUC), Florence (Italy)

8 More presentations in this session

Presentation thumbnail
Epidemiology and prognosis of obstructive and non-obstructive hypertrophic cardiomyopathy in Finland: a nationwide cohort study
Assistant Professor M. Laine (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Functional capacity by cardiopulmonary exercise testing is not related to health status in obstructive hypertrophic cardiomyopathy
Doctor L. Bjerregaard (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
Hemodynamic effects of right and biventricular pacing during exercise in hypertrophic obstructive cardiomyopathy
Doctor T. Ahmed (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Evaluation of clinical need, effectiveness, and safety of the first myosin inhibitor mavacamten in real world patients
Doctor L. Seuthe (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany
Associate Professor F. Sedaghat-Hamedani (Heidelberg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock

The Event

Event poster

ESC Congress 2024

30 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Exploring the effects of mavacamten through hemodynamic force analysis in patients with obstructive hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Non-obstructive hypertrophic cardiomyopathy exhibit subclinical abnormalities in systolic and diastolic ventricular kinetic energy and systolic haemodynamic forces on 4D flow CMR
thumbnail
Congress Presentation
Can haemodynamic force analysis be used to identify cancer treatment-related cardiac dysfunction? A comparison with strain and ejection fraction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources